戻る Agenda
Session 2: Current Developments in Clinical Trial Disclosure
Session Chair(s)
Matthias Zerm, PHD
Lead Expert, Clinical Trial Disclosure and R&D Processes
Germany
Robert Paarlberg, MS
Principal
Paarlberg & Associates LLC, United States
The National Library of Medicine (NLM) previously launched an effort to modernize ClinicalTrials.gov to deliver an improved user experience on an updated platform that will accommodate growth and enhance efficiency. Hear from ClinicalTrials,gov about the latest updates on the Modernization initiative.
With many thousands of clinical trials conducted every year, China has become an ever more important place for clinical research. Learn about the latest updates on clinical trial disclosure in China, both for drug as well as for medical device trials.
Speaker(s)
CTgov Update
Anna Fine, PHARMD, MS
National Institutes of Health (NIH), United States
Interim Director for ClinicalTrials.gov
Update on Drug and Device Trials- China
Adian Maloney, MS, RAC
BeiGene, United States
Data Disclosure & Transparency Associate